CliffBio
small molecule

CLOMID

CLOMIPHENE CITRATE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLOMID
Active ingredientCLOMIPHENE CITRATE
Strength50MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalAugust 1999
Marketing statusRX

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.